These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 36337766)

  • 1. Acupuncture or cupping plus standard care versus standard care in moderate to severe COVID-19 patients: An assessor-blinded, randomized, controlled trial.
    Alipour R; Jamalimoghadamsiahkali S; Karimi M; Asadi A; Ghaem H; Adel-Mehraban MS; Kazemi AH
    Integr Med Res; 2022 Dec; 11(4):100898. PubMed ID: 36337766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic respiratory and functional rehabilitation protocol for intensive care unit patients affected by COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Carvalho AC; Moreira J; Cubelo P; Cantista P; Branco CA; Guimarães B
    Trials; 2021 Apr; 22(1):268. PubMed ID: 33845878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of topical galbanum oil with dry cupping in hospitalized COVID-19 patients: A randomized open-label clinical trial.
    Seydi F; Salehi M; Hashem-Dabaghian F; Emadi F; Gholami-Fesharaki M; Iranzadasl M
    Avicenna J Phytomed; 2023; 13(4):388-399. PubMed ID: 37663385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warm Cupping of the Posterior Thorax in Combination with Standard Conventional Therapy for ARDS in COVID-19 Patients in ICU: a Case Series.
    Karimi M; Kazemi AH; Asadi A; Zarei A; Zargaran A; Moravej SAA; Jazayeri SF; Nabavian O; Ahmadi SA; Alipour R
    J Acupunct Meridian Stud; 2022 Jun; 15(3):194-200. PubMed ID: 35770550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
    Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M
    Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
    Alavi Darazam I; Hatami F; Rabiei MM; Pourhoseingholi MA; Moradi O; Shokouhi S; Hajesmaeili MR; Shabani M; Irvani SSN
    Trials; 2020 Oct; 21(1):880. PubMed ID: 33106183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Safa O; Hassani-Azad M; Farashahinejad M; Davoodian P; Dadvand H; Hassanipour S; Fathalipour M
    Trials; 2020 Sep; 21(1):790. PubMed ID: 32933552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a diet based on Iranian traditional medicine on inflammatory markers and clinical outcomes in COVID-19 patients: A double-blind, randomized, controlled trial.
    Hajibeygi R; Mirghazanfari SM; Pahlavani N; Jalil AT; Alshahrani SH; Rizaev JA; Hadi S; Hadi V; Yekta NH
    Eur J Integr Med; 2022 Oct; 55():102179. PubMed ID: 36035633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cupping therapy versus acupuncture for pain-related conditions: a systematic review of randomized controlled trials and trial sequential analysis.
    Zhang YJ; Cao HJ; Li XL; Yang XY; Lai BY; Yang GY; Liu JP
    Chin Med; 2017; 12():21. PubMed ID: 28770000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
    Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
    Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
    Samimagham HR; Azad MH; Hooshyar D; Haddad M; Arabi M; KazemiJahromi M
    Trials; 2021 Jul; 22(1):435. PubMed ID: 34229729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Ziaei A; Davoodian P; Dadvand H; Safa O; Hassanipour S; Omidi M; Masjedi M; Mahmoudikia F; Rafiee B; Fathalipour M
    Trials; 2020 Oct; 21(1):882. PubMed ID: 33106171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.